Radiology in the immune checkpoint inhibitor era

Benjamin C. Park*, Douglas B. Johnson, Robert J. Lewandowski

*Corresponding author for this work

Research output: Contribution to journalEditorialpeer-review


The field of oncology has undergone rapid changes following the introduction of immunotherapies and biologics. However, these changes have also created new roles for radiology in both diagnosis and treatment. Our article addresses the evolving role of radiology in the immune checkpoint inhibitor era of oncology. With the progression of new immunotherapies for cancer, imaging paradigms and image guided therapy options have changed. Multidisciplinary oncology teams should be aware of these opportunities for collaboration.

Original languageEnglish (US)
Article number110080
JournalClinical Imaging
StatePublished - Mar 2024


  • Immune checkpoint inhibitors
  • Immune related adverse events
  • Interventional oncology
  • Oncologic imaging

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging


Dive into the research topics of 'Radiology in the immune checkpoint inhibitor era'. Together they form a unique fingerprint.

Cite this